China, Emerging Markets In Focus For Genentech On Broad Avastin Access In Cervical Cancer

U.S. FDA approval is fifth indication for Roche/Genentech’s Avastin. The number of cases in the U.S. is low and set to decline with better prevention, but disease is still considered a major global health problem.